Pancreatic cancer index
Hello, Doctor! I am 34 years old this year.
I discovered an elevated CA19-9 level (64) in 2009.
At that time, I underwent various tests, including MRI and endoscopy, which revealed a 9 cm benign focal nodular hyperplasia (FNH) in the liver, while the pancreas and other organs showed no issues.
After that, I monitored my CA19-9 levels for over a year, which remained between 60 and 80.
After three years without follow-up, a health check in November 2013 showed a spike in CA19-9 to 117.
A few days later, a retest still showed an elevated level of 98, and in December, the level was 95.
An initial ultrasound examination did not reveal any abnormalities, and I have not experienced any discomfort or unusual symptoms.
I would like to ask the doctor: 1.
I have heard that if it were cancer, the CA19-9 levels would significantly increase upon retesting after a month.
Since my CA19-9 levels did not change much in the following month, can I feel more reassured? 2.
Given that I have had elevated CA19-9 levels since 2009 and have had no issues for over four years, does this recent increase still fall within a range that can be monitored, or do I need to undergo another detailed examination? Thank you!
Wing, 30~39 year old female. Ask Date: 2014/01/10
Dr. Cai Anshun reply Gastroenterology and Hepatology
Hello: CA 19-9 levels may be elevated in patients with pancreatic cancer, cholangiocarcinoma, liver cancer, gastric cancer, and colorectal cancer.
However, elevated CA 19-9 levels can also occur in patients without cancer, such as those with liver cirrhosis, cholangitis, hepatitis, pancreatitis, and benign gastrointestinal diseases.
Therefore, CA 19-9 should only be used as an auxiliary tool and cannot serve as definitive evidence for the presence of malignant disease.
It is recommended that any questions be directed to a clinical physician to determine if further examination or observation is necessary.
Changhua Hospital cares about your health.
Dr.
Tsai An-Shun.
Reply Date: 2014/01/10
More Info
CA 19-9 is a tumor marker primarily associated with pancreatic cancer, but it can also be elevated in other conditions, including benign diseases and other malignancies. Your case presents a complex history of elevated CA 19-9 levels, and it’s understandable to have concerns about what these readings mean for your health.
1. Understanding CA 19-9 Levels: Elevated CA 19-9 levels can indicate the presence of certain cancers, particularly pancreatic cancer, but they can also be elevated in conditions such as cholangitis, pancreatitis, and liver diseases. In your case, the initial finding of a benign focal nodular hyperplasia (FNH) in the liver is significant. FNH is generally considered a benign condition and does not typically lead to elevated CA 19-9 levels.
The fluctuation of your CA 19-9 levels from 64 to 117 and then back down to 95 suggests that while there is some variability, it is not necessarily indicative of cancer progression. It is important to note that CA 19-9 is not a definitive test for cancer; rather, it is used in conjunction with other diagnostic tools and clinical evaluations.
2. Interpreting Changes in CA 19-9 Levels: You mentioned that you have heard that if cancer is present, CA 19-9 levels would significantly rise within a month. While this can be true in some cases, it is not a hard and fast rule. The stability of your CA 19-9 levels over the subsequent months (from 117 to 98 and then 95) may provide some reassurance, but it is essential to consider this in the context of your overall health and any symptoms you may experience.
3. Follow-Up and Monitoring: Given your history of elevated CA 19-9 levels since 2009 and the recent fluctuations, it is prudent to continue monitoring these levels. Regular follow-up with your healthcare provider is essential. They may recommend periodic blood tests to track your CA 19-9 levels and possibly imaging studies to monitor the liver and pancreas for any changes.
If your healthcare provider believes that the current levels are still within a range that can be monitored, they may not recommend immediate additional imaging. However, if there are any new symptoms or if the levels continue to rise, further investigation may be warranted.
4. When to Seek Further Evaluation: If you experience any new symptoms such as unexplained weight loss, jaundice, abdominal pain, or changes in bowel habits, it is crucial to seek medical attention promptly. These could be signs of a more serious condition that requires further evaluation.
In conclusion, while your CA 19-9 levels have shown some fluctuations, the absence of significant symptoms and the benign nature of your previously identified liver condition may suggest that immediate concern is not warranted. However, continuous monitoring and open communication with your healthcare provider are key to ensuring your health remains stable. Regular check-ups and being proactive about any changes in your health will help in managing your situation effectively.
Similar Q&A
Understanding CA 19-9 Levels: What Mild Abnormalities Mean for Your Health
The CA 19-9 test shows a slight abnormality in your health check. What does this mean? Given my age, what could be the reasons for the elevated levels? Thank you.
Dr. Huang Zhihui reply Surgery
CA 19-9 is a tumor marker that is primarily elevated in cancers of the liver, bile ducts, and pancreas. The normal value is < 37 U/mL. However, a level above 120 U/mL is typically required to have diagnostic significance (indicating a high suspicion of cancer). Conditions such...[Read More] Understanding CA 19-9 Levels: What Mild Abnormalities Mean for Your Health
Understanding CA19-9 Levels: When to Worry About Pancreatic Health
Hello doctor, three years ago my CA 19-9 level was over 5, and during a health check in February this year, it increased to over 15. After another check two months later, it rose to over 17. All other biochemical test results are normal, except for a fasting blood sugar of 101. I...
Dr. Chen Shidian reply Gastroenterology and Hepatology
CA 19-9 cannot be used to diagnose cancer. If the abdominal ultrasound is normal, it can be monitored; however, if there are still concerns, a self-paid MRI may be considered.[Read More] Understanding CA19-9 Levels: When to Worry About Pancreatic Health
Understanding CA19-9 Levels: What a Decrease Means for Cancer Risk
Hello Doctor: I previously consulted you about my elevated CA 19-9 levels, which have been high since 2009. After a recheck at the end of November last year, my CA 19-9 level was 117. Two and a half months later, in early February this year, my CA 19-9 level decreased slightly to...
Dr. Chen Qifeng reply Gastroenterology and Hepatology
Hello: CA 19-9 is a marker with high sensitivity but low specificity. It can be elevated in cases of benign tumors, malignant tumors, and other conditions. Additionally, factors such as race and individual constitution can significantly influence the levels. Generally speaking, i...[Read More] Understanding CA19-9 Levels: What a Decrease Means for Cancer Risk
Understanding CA19-9 Levels: When to Seek Further Gastrointestinal Evaluation
Hello: My health check results show a CA 19-9 value of 40.2. Should I undergo further testing, and which department should I consult? Thank you!
Dr. Su Baojia reply Gastroenterology and Hepatology
CA19-9 > 37 requires further examination for gastrointestinal and hepatobiliary diseases, such as gallstones, bile duct obstruction, and liver function abnormalities, which can also cause an elevation in CA19-9 levels. Therefore, it is recommended that you consult a gastroente...[Read More] Understanding CA19-9 Levels: When to Seek Further Gastrointestinal Evaluation
Related FAQ
(Gastroenterology and Hepatology)
Ca199(Gastroenterology and Hepatology)
Liver Enzyme Levels(Gastroenterology and Hepatology)
Blood Test(Gastroenterology and Hepatology)
Weight(Gastroenterology and Hepatology)
Fecal Occult Blood(Gastroenterology and Hepatology)
Ct Scan(Gastroenterology and Hepatology)
Diet(Gastroenterology and Hepatology)
Colonoscopy(Gastroenterology and Hepatology)
Bilirubin(Gastroenterology and Hepatology)